Classification and Generations of Drugs
This pharmacological group is part of the antisecretory drugs, alongside proton pump inhibitors and muscarinic receptor antagonists (M-anticholinergics). H2-receptor blockers are categorized into several generations:
- Cimetidine — first-generation representative.
- Ranitidine — second-generation, active for up to 10–12 hours and more potent than its predecessor.
- Famotidine — third-generation with a favorable tolerability profile.
- Nizatidine and Roxatidine — fourth and fifth generations possessing a dual mechanism of action.
Pharmacodynamics and Mechanism of Action
These drugs block the effects of histamine released by enterochromaffin-like cells. This produces the following effects:
- Inhibition of hydrochloric acid secretion by parietal cells.
- Reduction of basal acid secretion at rest and during the day.
- Decrease in nocturnal acid output.
- Suppression of pepsin synthesis.
Later generations (nizatidine and roxatidine) additionally stimulate protective mucus production and normalize gastrointestinal motility.
Clinical Application and Dosing
These agents are used for gastric and duodenal peptic ulcer disease, hyperacid states, as well as Zollinger-Ellison syndrome and NSAID-induced ulcers.
- Cimetidine: prescribed 3 times a day plus at bedtime for a course of 4–8 weeks. Abrupt discontinuation causes rebound syndrome with ulcer recurrence.
- Ranitidine: taken twice daily.
- Famotidine: used for acute ulcer exacerbation at a dose of 40 mg once daily at bedtime.
Side Effects and Interactions
The safety profile varies depending on the generation and specific active substance:
- Cimetidine: causes antiandrogenic effects (hyperprolactinemia, galactorrhea, gynecomastia, impotence), diarrhea, and renal and hepatic impairment. It acts as a microsomal oxidation inhibitor, suppressing cytochrome P450 and slowing the metabolism of tricyclic antidepressants and anticoagulants.
- Ranitidine: rarely produces adverse reactions (occasional constipation or headaches) and does not affect the metabolism of other medications.
- Famotidine: is generally well tolerated, but has limitations: contraindicated during pregnancy, lactation, and in pediatric patients.